← Open Payments lookup

CASSIDY DICKSON: Open Payments

NPI 1609333947 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,002 in 51 payments from 17 companies in 2025. Trend: 2023 $1,228 · 2024 $1,884 · 2025 $1,002

Food & beverage: $1,002
CompanyPaymentsAmount
ABBVIE INC.13$279
GENZYME CORPORATION4$123
Celltrion USA Inc.6$106
Janssen Biotech, Inc.5$96
Madrigal Pharmaceuticals3$68
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$59
Lilly USA, LLC2$39
Takeda Pharmaceuticals U.S.A., Inc.2$37
Gilead Sciences, Inc.2$32
Aimmune Therapeutics, Inc.2$28

Products named: DUPIXENT, VEGZELMA, TREMFYA, REZDIFFRA, LINZESS, CREON, XIFAXAN, OMVOH.

Industry payments across AL — which companies pay providers there.